Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Basal Cell 6 Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 4 Pancreatic Neoplasms 3 Cholangiocarcinoma 3 Tongue Neoplasms 2 Pleural Diseases 2 Mycosis Fungoides 2 Mesothelioma, Malignant 2 Keratosis, Actinic 2 Bile Duct Neoplasms 2 Basal Cell Nevus Syndrome 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stomatitis 1 Skin Neoplasms 1 Sezary Syndrome 1 Salivary Gland Neoplasms 1 Photosensitivity Disorders 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pain 1 Neoplasms 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoid Interstitial Pneumonia 1 Lung Neoplasms 1 Esthesioneuroblastoma, Olfactory 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Epitheliod Malignant Pleural Mesothelioma 1 Colorectal Neoplasms 1

Interventions

Low-Level Light Therapy 10 Standard of Care 4 Propolis 4 Cryotherapy 4 Sodium Bicarbonate 3 Laser Therapy 3 Control Groups 3 Water 2 Vitamin E 2 Vitamin B 12 2 Sodium Chloride 2 Saliva, Artificial 2 Practice Guidelines as Topic 2 Mouthwashes 2 Honey 2 Glutamine 2 Gentamicins 2 Cisplatin 2 Chlorhexidine 2 Ascorbic Acid 2 Acetylcysteine 2 whole grape extract 1 sargramostim 1 samital 1 regramostim 1 peppermint oil 1 oxycodone-acetaminophen 1 holy basil leaf extract 1 calcium phosphate 1 ankaferd blood stopper 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Stomatitis × 1-phenyl-3,3-dimethyltriazene × Clear all

NCT02555501 2015-09-21

OMLTPT

Universidade Ceuma

Phase 3 Completed

Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡